Association Study of Interferon-γ, Cytosolic Phospholipase A2, and Cyclooxygenase-2 Gene Polymorphisms in Alzheimer Disease

被引:21
作者
Feher, Agnes [1 ]
Juhasz, Anna [1 ]
Rimanoczy, Agnes [1 ]
Kalman, Janos [1 ]
Janka, Zoltan [1 ]
机构
[1] Univ Szeged, Dept Psychiat, H-6725 Szeged, Hungary
基金
匈牙利科学研究基金会;
关键词
interferon-gamma; cytosolic phospholipase A2; cyclooxygenase-2; Alzheimer disease; single nucleotide polymorphism; SINGLE NUCLEOTIDE POLYMORPHISM; PROTECTIVE FACTOR; 1ST INTRON; SCHIZOPHRENIA; ALLELE;
D O I
10.1097/JGP.0b013e3181e70c05
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
030301 [社会学]; 100201 [内科学];
摘要
Objective: The increased production of proinflammatory mediators such as cytokines and prostaglandins may interact at multiple levels with neurodegeneration in Alzheimer disease (AD). This study was undertaken to evaluate the possible role of interferon-gamma (IFN-gamma) T+874A, cytoplasmic phospholipase A(2) (cPLA2) BanI, and cyclooxygenase-2 (COX-2) G-765C polymorphisms in AD. Methods: The study included 237 probable patients with AD who met the diagnostic criteria of National Institute of Neurological and Communicative Disorders and Stroke-AD and Related Disorders Association, and 245 probands in the healthy comparison (HC) group. Results: No significant difference in mean age or in the distribution of genders between AD and HC groups was found. The COX-2 G/G genotype was significantly more frequent in the AD, when compared with the HC group. There was no significant correlation between IFN-gamma or cPLA2 genotypes and AD. Conclusions: Our findings indicate that the COX-2 G/G genotype is associated with AD and support the involvement of COX-2 in AD etiology. (Am J Geriatr Psychiatry 2010; 18: 983-987)
引用
收藏
页码:983 / 987
页数:5
相关论文
共 21 条
[1]
The cyclooxygenase 2-765 C promoter allele is a protective factor for Alzheimer's disease [J].
Abdullah, L ;
Ait-Ghezala, G ;
Crawford, F ;
Crowell, TA ;
Barker, WW ;
Duara, R ;
Mullan, M .
NEUROSCIENCE LETTERS, 2006, 395 (03) :240-243
[2]
Interferon-γ increases neuronal death in response to amyloid-β1-42 [J].
Bate, Clive ;
Kempster, Sarah ;
Last, Victoria ;
Williams, Alun .
JOURNAL OF NEUROINFLAMMATION, 2006, 3 (1)
[3]
Does IFNγ play a role in neurodegeneration? [J].
Blasko, I ;
Ransmayr, G ;
Veerhuis, R ;
Eikelenboom, P ;
Grubeck-Loebenstein, B .
JOURNAL OF NEUROIMMUNOLOGY, 2001, 116 (01) :1-4
[4]
Meta-analysis of linkage studies for Alzheimer's disease-A web resource [J].
Butler, Amy W. ;
Ng, Mandy Y. M. ;
Hamshere, Marian L. ;
Forabosco, Paola ;
Wroe, Richard ;
Al-Chalabi, Ammar ;
Lewis, Cathryn M. ;
Powell, John F. .
NEUROBIOLOGY OF AGING, 2009, 30 (07) :1037-1047
[5]
Association studies of cytosolic phospholipase A2 polymorphisms and schizophrenia among two independent family-based samples [J].
Chowdari, KV ;
Brandstaetter, B ;
Semwal, P ;
Bhatia, T ;
Deshpande, S ;
Reddy, R ;
Wood, J ;
Weinberg, CR ;
Thelma, BK ;
Nimgaonkar, VL .
PSYCHIATRIC GENETICS, 2001, 11 (04) :207-212
[6]
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke [J].
Cipollone, F ;
Toniato, E ;
Martinotti, S ;
Fazia, M ;
Iezzi, A ;
Cuccurullo, C ;
Pini, B ;
Ursi, S ;
Vitullo, G ;
Averna, M ;
Arca, M ;
Montali, A ;
Campagna, F ;
Ucchino, S ;
Spigonardo, F ;
Taddei, S ;
Virdis, A ;
Ciabattoni, G ;
Notarbartolo, A ;
Cuccurullo, F ;
Mezzetti, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (18) :2221-2228
[7]
+874(T→A) single nucleotide gene polymorphism does not represent a risk factor for Alzheimer's disease [J].
Galimberti L. ;
Arosio B. ;
Calabresi C. ;
Scurati S. ;
Hamilton S. ;
Delli Carpini S. ;
Vergani C. ;
Annoni G. .
Immunity & Ageing, 1 (1)
[8]
Inflammatory processes in Alzheimer's disease [J].
Heneka, Michael T. ;
O'Banion, M. Kerry .
JOURNAL OF NEUROIMMUNOLOGY, 2007, 184 (1-2) :69-91
[9]
Cyclooxygenase-1 and-2 in the different stages of Alzheimer's disease pathology [J].
Hoozemans, J. J. M. ;
Rozemuller, J. M. ;
van Haastert, E. S. ;
Veerhuis, R. ;
Eikelenboom, P. .
CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (14) :1419-1427
[10]
Non-steroidal anti-inflammatory drug (NSAID) use and Alzheimer disease in community-dwelling elderly patients [J].
Landi, F ;
Cesari, M ;
Onder, G ;
Russo, A ;
Torre, S ;
Bernabei, R .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 11 (02) :179-185